Related Experiment Videos
[Advanced breast biopsy instrumentation (ABBI) experiences and critical comments]
K Hergan1, A Haid, M Türtscher
1Zentrales Institut für Radiologie, Institut für pathologie, Feldkirch, Germany. klaus.hergan@lkhf.at
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|October 6, 2001
Summary
Advanced breast biopsy instrumentation (ABBI) proved too invasive and costly for evaluating breast lesions. Its high failure rate and low therapeutic effectiveness led to a significant decline in its use over three years.
Area of Science:
- Oncology
- Radiology
- Surgical Pathology
Background:
- Advanced breast biopsy instrumentation (ABBI) is a technique used for breast lesion evaluation.
- This study retrospectively analyzes three years of experience with ABBI.
Purpose of the Study:
- To describe the clinical experience with ABBI over a three-year period.
- To critically evaluate the effectiveness and efficiency of ABBI in breast lesion diagnosis and treatment.
Main Methods:
- Eighty-nine patients underwent ABBI based on lesion characteristics and patient criteria.
- Data analyzed included procedure duration, complications, histologic outcomes, and subsequent treatments.
Main Results:
- ABBI was successful in 63 of 89 patients (71%).
- Cancer was diagnosed in 18 patients (29%), with an 89% re-excision rate for clear margins.
- ABBI failed or required alternative methods in 26 patients (29%), with a 63% overall reduction in ABBI use over three years.
Conclusions:
- ABBI is considered too invasive and expensive for breast lesion evaluation.
- Its ineffectiveness as a therapeutic tool for lesion removal is noted.
- ABBI is not recommended over other available biopsy techniques.